UltraSight Ultrasound AI

Description

UltraSight introduces a groundbreaking solution in cardiac ultrasound technology with its AI-driven software that offers real-time guidance to healthcare professionals. This innovative software is designed to empower medical practitioners of all skill levels to consistently produce diagnostic-quality cardiac ultrasound images. Whether in clinics, hospitals, ambulances, or remote areas, UltraSight enhances the ease, quality, and availability of cardiac imaging, enabling more accurate and timely clinical decisions.

UltraSight’s technology has been validated by a pivotal study showing that even novice users can, after minimal training, acquire images comparable to those obtained by expert sonographers. The software supports the acquisition of standard cardiac views and integrates seamlessly with existing ultrasound systems, such as the Philips Lumify system, to enhance diagnostic capabilities without the need for extensive sonography experience.

Awarded for its innovation, including the Bristol Myers Squibb Improving Cardiovascular Disease Outcomes Challenge, UltraSight’s real-time guidance solution is FDA approved, UKCA and CE marked, and AMAR cleared. It signifies a major advance in making cardiac care more accessible and effective, contributing to better patient outcomes through innovative technology.